Want to join the conversation?
Laboratory instruments and services provider $A reported higher 2Q16 net income as a result of higher revenues. Net income was $91MM or $0.28 per diluted share compared to $87MM or $0.26 per diluted share in 2Q15. Revenue of $1.02Bil was up 6% YoverY for 2Q16. Non-GAAP income from continuing operations was $145MM or $0.44 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?